Michael Adams presents this exclusive CEO-Roaster Video Interview with Entheon Biomedical Corp.

Guest:
Timothy Ko, CEO & Director of Entheon Biomedical Corp.

Company:
$ENBI Entheon Biomedical Corp. (CSE: AVU) (US Pink: ENTBF) (FSE: 1XU1) (WKN: A2QJBZ)

A New Dimension In Addiction Treatment

#ENBI
#EntheonBiomedical

Venue & Date:
Taped online on January 25, 2021

Find more info on

aktuell

Disclaimer:

CEO-Roaster.com feature stock reports and interviews are intended to be stock ideas, NOT recommendations. Please do your own research before investing.

CEO-Roaster.com is not a Registered Broker/Dealer or Financial Advisor, nor do we hold ourselves out to be. Before making a purchase or sale of any securities featured on our web site or mentioned in our reports, we strongly encourage and recommend consultation with a registered securities representative.

All investors are cautioned that they may lose all or a portion of their investment if they decide to make a purchase in any of our profiled companies. Past performance of our profiled stocks is not indicative of future results. The accuracy or completeness of the information on our web site or within our reports is only as reliable as the sources they were obtained from. The profile and opinions expressed herein are expressed as of the date the profile is posted on site and are subject to change without notice. No investor should assume that reliance on the views; opinions or recommendations contained herein will produce profitable results. CEO–Roaster.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our web site or within our reports.

THE READER/VIEWER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SMALL CAP SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

PLEASE READ OUR FULL DISCLAIMER AT

Conflict of interests

source